Core Insights - Vivos Therapeutics, Inc. is a medical device and technology company focused on developing proprietary treatments for sleep-related breathing disorders, particularly obstructive sleep apnea (OSA) and snoring in both adults and children [1][3] - The company is transitioning to a medical-based business model and is actively seeking partnerships with physician-based sleep groups to enhance its market presence [2][4] Company Overview - Vivos Therapeutics specializes in innovative diagnostic and treatment methods for breathing and sleep issues caused by dentofacial abnormalities, with a focus on the Vivos Method, which is a non-surgical and non-invasive solution for OSA [3][4] - The Vivos Method has been clinically effective for over 47,000 patients treated globally by more than 2,000 trained dentists [3] Product and Treatment Details - The Vivos Method employs proprietary CARE appliance therapy to modify the jaw and soft tissues of the upper airway, significantly reducing symptoms associated with OSA [4] - Vivos also offers SleepImage diagnostic technology for home sleep testing and provides training and services to dentists through its Vivos Integrated Practice (VIP) program [4] Upcoming Events - CEO Kirk Huntsman will participate in a fireside chat to discuss the company's strategies, market dynamics, and the role of Vivos CARE devices in OSA treatment [1][2]
Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.